{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:52:23Z","timestamp":1791139943710,"version":"4.1.0"},"reference-count":202,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.autrev.2011.01.004","type":"journal-article","created":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T09:24:52Z","timestamp":1296552292000},"page":"416-425","source":"Crossref","is-referenced-by-count":92,"title":["Comparative assessment of vascular function in autoimmune rheumatic diseases: Considerations of prevention and treatment"],"prefix":"10.1016","volume":"10","author":[{"given":"P\u00e1l","family":"Solt\u00e9sz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Kerekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriett","family":"D\u00e9r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Sz\u00fccs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1ndor","family":"Sz\u00e1nt\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emese","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Bodolay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margit","family":"Zeher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Tim\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Szodoray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyula","family":"Szegedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Szekanecz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0010","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ncprheum0092","article-title":"Mechanisms of disease: atherosclerosis in autoimmune diseases","volume":"2","author":"Sherer","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"21","key":"10.1016\/j.autrev.2011.01.004_bb0015","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1161\/CIRCULATIONAHA.104.507996","article-title":"Accelerated atherosclerosis in autoimmune rheumatic diseases","volume":"112","author":"Shoenfeld","year":"2005","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0020","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/hq1201.100220","article-title":"Immune mechanisms in atherosclerosis","volume":"21","author":"Hansson","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.01.004_bb0025","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1538-7836.2009.03416.x","article-title":"Inflammatory mechanisms in atherosclerosis","volume":"7","author":"Hansson","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"23","key":"10.1016\/j.autrev.2011.01.004_bb0030","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.01.004_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1556\/OH.2007.28036","article-title":"The autoimmune features of vasculopathies","volume":"148","author":"Soltesz","year":"2007","journal-title":"Orv Hetil"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0040","first-page":"529","article-title":"Pro-inflammatory cytokines in atherosclerosis","volume":"10","author":"Szekanecz","year":"2008","journal-title":"Isr Med Assoc J"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1161\/01.ATV.9.5.567","article-title":"Immune mechanisms in atherosclerosis","volume":"9","author":"Hansson","year":"1989","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.autrev.2011.01.004_bb0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2249.2009.03885.x","article-title":"Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis","volume":"156","author":"Tervaert","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0055","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.crd.0000124843.85660.ed","article-title":"Atherosclerosis and systemic lupus erythematosus","volume":"12","author":"Abusamieh","year":"2004","journal-title":"Cardiol Rev"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2009.09281.x","article-title":"More than skin deep: atherosclerosis as a systemic manifestation of psoriasis","volume":"161","author":"Alexandroff","year":"2009","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/096120339400300503","article-title":"Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus: a unifying \u2018membrane stress syndrome\u2019 hypothesis","volume":"3","author":"Ames","year":"1994","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0070","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.autrev.2007.06.002","article-title":"Insights into atherosclerosis therapy in antiphospholipid syndrome","volume":"7","author":"Belizna","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0075","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0889-857X(05)70138-1","article-title":"Premature atherosclerosis in systemic lupus erythematosus","volume":"26","author":"Bruce","year":"2000","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2011.01.004_bb0080","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1196\/annals.1422.038","article-title":"Precocious atherosclerosis in rheumatoid arthritis: role of traditional and disease-related cardiovascular risk factors","volume":"1108","author":"Gerli","year":"2007","journal-title":"Ann NY Acad Sci"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0085","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1385\/CRIAI:25:1:79","article-title":"Atherosclerosis and antiphospholipid syndrome","volume":"25","author":"Jara","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.autrev.2011.01.004_bb0090","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1177\/096120339800700230","article-title":"Antiphospholipid antibodies and atherosclerosis","volume":"7","author":"Matsuura","year":"1998","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0095","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11926-003-0032-6","article-title":"The antiphospholipid syndrome and atherosclerosis: clue to pathogenesis","volume":"5","author":"Merrill","year":"2003","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0100","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11883-001-0027-6","article-title":"Antiphospholipid syndrome, antiphospholipid antibodies, and atherosclerosis","volume":"3","author":"Sherer","year":"2001","journal-title":"Curr Atheroscler Rep"},{"issue":"Suppl 2","key":"10.1016\/j.autrev.2011.01.004_bb0105","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1177\/096120339800700231","article-title":"Atherosclerosis and the antiphospholipid syndrome: a link unravelled?","volume":"7","author":"Shoenfeld","year":"1998","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0110","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/rheumatology\/kel426","article-title":"Endothelial dysfunction precedes atherosclerosis in systemic sclerosis\u2014relevance for prevention of vascular complications","volume":"46","author":"Szucs","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0115","first-page":"398","article-title":"Endothelial dysfunction and atherosclerosis in rheumatoid arthritis: a multiparametric analysis using imaging techniques and laboratory markers of inflammation and autoimmunity","volume":"35","author":"Kerekes","year":"2008","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0120","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10067-009-1118-y","article-title":"A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases","volume":"28","author":"Soltesz","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.004_bb0125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1196\/annals.1422.036","article-title":"Accelerated atherosclerosis in rheumatoid arthritis","volume":"1108","author":"Szekanecz","year":"2007","journal-title":"Ann NY Acad Sci"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0130","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/ar2515","article-title":"Vascular involvement in rheumatic diseases: \u2018vascular rheumatology\u2019","volume":"10","author":"Szekanecz","year":"2008","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0135","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/MD.0b013e3181c10773","article-title":"The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease","volume":"88","author":"Gonzalez-Juanatey","year":"2009","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0140","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/BOR.0b013e328133f58e","article-title":"Cardiovascular risks in spondyloarthritides","volume":"19","author":"Heeneman","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.004_bb0145","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0150","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/ard.2008.094839","article-title":"Cardiovascular morbidity in psoriatic arthritis","volume":"68","author":"Gladman","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0155","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/art.22530","article-title":"Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0160","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s00296-005-0616-8","article-title":"Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost","volume":"26","author":"Vegh","year":"2006","journal-title":"Rheumatol Int"},{"issue":"Suppl 1","key":"10.1016\/j.autrev.2011.01.004_bb0165","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0167-5273(00)00196-0","article-title":"Vasa vasoritis, vasculitis and atherosclerosis","volume":"75","author":"Numano","year":"2000","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.autrev.2011.01.004_bb0170","doi-asserted-by":"crossref","unstructured":"Gerli R, Vaudo G, Bocci EB, Schillaci G, Alunno A, Luccioli F, et al. Functional impairment of the arterial wall in primary Sjogren's syndrome: combined action of immunologic and inflammatory factors. Arthritis Care Res (Hoboken) 2010;62(5):712\u20138.","DOI":"10.1002\/acr.20117"},{"key":"10.1016\/j.autrev.2011.01.004_bb0175","doi-asserted-by":"crossref","unstructured":"Sarzi-Puttini P, Atzeni F, Gerli R, Bartoloni E, Doria A, Barskova T, et al. Cardiac involvement in systemic rheumatic diseases: an update. Autoimmun Rev 2010;9(12):849\u201352.","DOI":"10.1016\/j.autrev.2010.08.002"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0180","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2008.08.004","article-title":"Cardiovascular involvement in systemic autoimmune diseases","volume":"8","author":"Sitia","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"10","key":"10.1016\/j.autrev.2011.01.004_bb0185","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.autrev.2010.05.018","article-title":"Endothelial dysfunction and vascular stiffness in systemic lupus erythematosus: are they early markers of subclinical atherosclerosis?","volume":"9","author":"Zardi","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0190","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.autrev.2009.11.002","article-title":"The heart in rheumatoid arthritis","volume":"9","author":"Turiel","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0195","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ncprheum0178","article-title":"Therapy insight: managing cardiovascular risk in patients with rheumatoid arthritis","volume":"2","author":"Giles","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0200","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.autrev.2010.07.017","article-title":"Effects of treatment strategy on endothelial function","volume":"9","author":"Tomasoni","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0205","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.autrev.2010.07.018","article-title":"The effect of pharmacological therapy on the cardiovascular system of patients with systemic rheumatic diseases","volume":"9","author":"Atzeni","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.01.004_bb0210","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1749-6632.2009.04645.x","article-title":"Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis","volume":"1173","author":"Kerekes","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.autrev.2011.01.004_bb0215","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10067-009-1095-1","article-title":"Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis","volume":"28","author":"Kerekes","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0220","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrrheum.2009.219","article-title":"Vascular effects of biologic agents in RA and spondyloarthropathies","volume":"5","author":"Szekanecz","year":"2009","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0225","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s11926-003-0006-8","article-title":"Atherosclerotic cardiovascular disease in rheumatoid arthritis","volume":"5","author":"del Rincon","year":"2003","journal-title":"Curr Rheumatol Rep"},{"issue":"10","key":"10.1016\/j.autrev.2011.01.004_bb0230","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.biopha.2006.09.006","article-title":"Cardiovascular disease in rheumatoid arthritis","volume":"60","author":"Gonzalez-Gay","year":"2006","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0235","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.bor.0000218951.65601.bf","article-title":"Cardiovascular disease in rheumatoid arthritis","volume":"18","author":"Kaplan","year":"2006","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0240","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/08916930903002453","article-title":"Endothelial damage and autoimmune diseases","volume":"42","author":"Kaplan","year":"2009","journal-title":"Autoimmunity"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0245","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/art.10089","article-title":"Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?","volume":"46","author":"Van Doornum","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2011.01.004_bb0250","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ncprheum0249","article-title":"Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis","volume":"2","author":"Klareskog","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2011.01.004_bb0255","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1002\/art.20553","article-title":"A gene\u2013environment interaction between smoking and shared epitope genes in HLA-DR provides a high risk of seropositive rheumatoid arthritis","volume":"50","author":"Padyukov","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.004_bb0260","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.autrev.2009.04.006","article-title":"Anti-citrullinated protein\/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis","volume":"9","author":"Szodoray","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0265","first-page":"2425","article-title":"Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis","volume":"33","author":"Dessein","year":"2006","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0270","first-page":"596","article-title":"High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis","volume":"26","author":"Gonzalez-Gay","year":"2008","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0275","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1097\/MEG.0b013e3282f16251","article-title":"Resistin is an inflammatory marker of inflammatory bowel disease in humans","volume":"19","author":"Konrad","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.autrev.2011.01.004_bb0280","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.cellsig.2008.04.003","article-title":"Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB\/p300 binding in human synovial fibroblasts","volume":"20","author":"Tong","year":"2008","journal-title":"Cell Signal"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0285","first-page":"1403","article-title":"Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis","volume":"30","author":"Dessein","year":"2003","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0290","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.atherosclerosis.2007.01.004","article-title":"Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis","volume":"196","author":"Chung","year":"2008","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0295","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.metabol.2008.10.002","article-title":"Plasma asymmetric dimethylarginine is related to anticitrullinated protein antibodies in rheumatoid arthritis of short duration","volume":"58","author":"Surdacki","year":"2009","journal-title":"Metabolism"},{"issue":"10 Suppl 1","key":"10.1016\/j.autrev.2011.01.004_bb0300","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.amjmed.2008.06.014","article-title":"Role of inflammation in atherosclerosis associated with rheumatoid arthritis","volume":"121","author":"Libby","year":"2008","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0305","first-page":"373","article-title":"Influence of anti-TNF-alpha infliximab therapy on adhesion molecules associated with atherogenesis in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0310","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/ar114","article-title":"Cell\u2013cell interactions in synovitis. Endothelial cells and immune cell migration","volume":"2","author":"Szekanecz","year":"2000","journal-title":"Arthritis Res"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0315","first-page":"124","article-title":"Cellular adhesion molecules in rheumatoid arthritis: regulation by cytokines and possible clinical importance","volume":"44","author":"Szekanecz","year":"1996","journal-title":"J Investig Med"},{"key":"10.1016\/j.autrev.2011.01.004_bb0320","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.med.45.1.361","article-title":"Endothelial-leukocyte adhesion molecules in human disease","volume":"45","author":"Bevilacqua","year":"1994","journal-title":"Annu Rev Med"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0325","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/art.23149","article-title":"Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis","volume":"58","author":"Farragher","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11926-001-0051-0","article-title":"Update on synovitis","volume":"3","author":"Szekanecz","year":"2001","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0335","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/BOR.0b013e32805e87ae","article-title":"Macrophages and their products in rheumatoid arthritis","volume":"19","author":"Szekanecz","year":"2007","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 2","key":"10.1016\/j.autrev.2011.01.004_bb0340","doi-asserted-by":"crossref","first-page":"ii43","DOI":"10.1136\/ard.62.suppl_2.ii43","article-title":"Metalloproteinases, inflammation, and rheumatoid arthritis","volume":"62","author":"Mohammed","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0345","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/hh1501.094396","article-title":"Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?","volume":"89","author":"Creemers","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.autrev.2011.01.004_bb0350","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1749-6632.1999.tb07674.x","article-title":"Design and synthetic considerations of matrix metalloproteinase inhibitors","volume":"878","author":"Skotnicki","year":"1999","journal-title":"Ann NY Acad Sci"},{"issue":"22","key":"10.1016\/j.autrev.2011.01.004_bb0355","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1161\/01.CIR.0000131450.66017.B3","article-title":"CD4+CD28\u2212 T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients","volume":"109","author":"Gerli","year":"2004","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0360","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0961203307076697","article-title":"Thickened carotid artery intima-media in rheumatoid arthritis is associated with elevated anticardiolipin antibodies","volume":"16","author":"Sherer","year":"2007","journal-title":"Lupus"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0365","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.autrev.2009.02.005","article-title":"Are autoantibodies triggering endothelial cell apoptosis really pathogenic?","volume":"8","author":"Tobon","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0370","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/14656566.9.7.1121","article-title":"Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs","volume":"9","author":"Avouac","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"10 Suppl 1","key":"10.1016\/j.autrev.2011.01.004_bb0375","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2008.06.010","article-title":"Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus","volume":"121","author":"Salmon","year":"2008","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0380","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force","volume":"39","author":"Corretti","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0385","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/01.STR.28.3.665","article-title":"Reproducibility of in vivo carotid intima-media thickness measurements: a review","volume":"28","author":"Kanters","year":"1997","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0390","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/HJH.0b013e3282f314f7","article-title":"A new oscillometric method for assessment of arterial stiffness: comparison with tonometric and piezo-electronic methods","volume":"26","author":"Baulmann","year":"2008","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0395","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semarthrit.2008.02.001","article-title":"Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis","volume":"38","author":"Gonzalez-Gay","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0400","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.autrev.2010.08.001","article-title":"Usefulness of cardiovascular biomarkers and cardiac imaging in systemic rheumatic diseases","volume":"9","author":"Atzeni","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0405","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/art.24308","article-title":"Short-term improvement of endothelial function in rituximab-treated rheumatoid arthritis patients refractory to tumor necrosis factor alpha blocker therapy","volume":"59","author":"Gonzalez-Juanatey","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0410","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s10067-009-1095-1","article-title":"Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis","volume":"28","author":"Kerekes","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0415","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/03009740802363768","article-title":"Sustained improvement of vascular endothelial function during anti-TNFalpha treatment in rheumatoid arthritis patients","volume":"38","author":"Sidiropoulos","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0420","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/art.10735","article-title":"Screening for atherosclerosis in patients with rheumatoid arthritis: comparison of two in vivo tests of vascular function","volume":"48","author":"Van Doornum","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0425","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.autrev.2010.07.016","article-title":"From endothelial dysfunction to atherosclerosis","volume":"9","author":"Sitia","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0430","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semarthrit.2004.11.007","article-title":"Duplex study of the carotid and femoral arteries of patients with rheumatoid arthritis: a controlled study","volume":"35","author":"Abu-Shakra","year":"2005","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0435","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10067-006-0338-7","article-title":"Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors","volume":"26","author":"Daza","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0440","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/art.11078","article-title":"Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects","volume":"48","author":"Del Rincon","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0445","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/ard.2007.073718","article-title":"Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis","volume":"67","author":"Gerli","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0450","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.semarthrit.2008.01.012","article-title":"Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis","volume":"38","author":"Gonzalez-Juanatey","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.004_bb0455","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1196\/annals.1361.069","article-title":"Early atherosclerosis in rheumatoid arthritis: effects of smoking on thickness of the carotid artery intima media","volume":"1051","author":"Gerli","year":"2005","journal-title":"Ann NY Acad Sci"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0460","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3899\/jrheum.090670","article-title":"Increased prevalence of carotid artery atherosclerosis in rheumatoid arthritis is artery-specific","volume":"37","author":"Kobayashi","year":"2010","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0465","doi-asserted-by":"crossref","first-page":"R36","DOI":"10.1186\/ar2641","article-title":"Coronary arterial calcification in rheumatoid arthritis: comparison with the Multi-Ethnic Study of Atherosclerosis","volume":"11","author":"Giles","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.01.004_bb0470","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3899\/jrheum.090667","article-title":"Signs of accelerated preclinical atherosclerosis in patients with ankylosing spondylitis","volume":"37","author":"Peters","year":"2010","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2011.01.004_bb0475","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2011.01.004_bb0480","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2007.02.004","article-title":"The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: roles of inflammation and dyslipidemia","volume":"28","author":"Hahn","year":"2007","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0485","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s10067-006-0380-5","article-title":"High prevalence of metabolic syndrome in patients with ankylosing spondylitis","volume":"26","author":"Malesci","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0490","first-page":"921","article-title":"Effects of infliximab treatment on lipoprotein profile in patients with rheumatoid arthritis and ankylosing spondylitis","volume":"33","author":"Kiortsis","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2011.01.004_bb0495","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jbspin.2009.05.012","article-title":"Effects of 14weeks of TNF alpha blockade treatment on lipid profile in ankylosing spondylitis","volume":"77","author":"Mathieu","year":"2010","journal-title":"Joint Bone Spine"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0500","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.24492","article-title":"Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis","volume":"60","author":"van Eijk","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0505","first-page":"626","article-title":"Antibodies against recombinant heat shock proteins of 60kDa from enterobacteria in the sera and synovial fluid of HLA-B27 positive ankylosing spondylitis patients","volume":"27","author":"Dominguez-Lopez","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"16","key":"10.1016\/j.autrev.2011.01.004_bb0510","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2169\/internalmedicine.48.2193","article-title":"Increased levels of asymmetric dimethylarginine (ADMA) in patients with ankylosing spondylitis","volume":"48","author":"Sari","year":"2009","journal-title":"Intern Med"},{"issue":"10","key":"10.1016\/j.autrev.2011.01.004_bb0515","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/rheumatology\/kel260","article-title":"Impaired endothelial function in patients with ankylosing spondylitis","volume":"45","author":"Pieringer","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0520","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/rheumatology\/kei145","article-title":"Impaired endothelial function in patients with ankylosing spondylitis","volume":"45","author":"Sari","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0525","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jbspin.2007.11.007","article-title":"No differences of carotid intima-media thickness between young patients with ankylosing spondylitis and healthy controls","volume":"75","author":"Choe","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"8","key":"10.1016\/j.autrev.2011.01.004_bb0530","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/rheumatology\/ken198","article-title":"Trend towards increased arterial stiffness or intima-media thickness in ankylosing spondylitis patients without clinically evident cardiovascular disease","volume":"47","author":"Mathieu","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"10.1016\/j.autrev.2011.01.004_bb0535","first-page":"2070","article-title":"Subclinical atherosclerosis in patients with psoriatic arthritis","volume":"35","author":"Gonzalez-Gay","year":"2008","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0540","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.semarthrit.2008.06.001","article-title":"Asymptomatic hyperuricemia and serum uric acid concentration correlate with subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease","volume":"39","author":"Gonzalez-Gay","year":"2009","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0545","first-page":"877","article-title":"Subclinical atherosclerosis in psoriatic arthritis: a case\u2013control study","volume":"35","author":"Eder","year":"2008","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0550","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.22884","article-title":"High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors","volume":"57","author":"Gonzalez-Juanatey","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0555","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","article-title":"Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis","volume":"36","author":"Kimhi","year":"2007","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2011.01.004_bb0560","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.24014","article-title":"Subclinical carotid atherosclerosis in patients with psoriatic arthritis","volume":"59","author":"Tam","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2011.01.004_bb0565","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1468-3083.2009.03481.x","article-title":"Subclinical atherosclerosis in patients with chronic psoriasis: a potential association","volume":"24","author":"El-Mongy","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0570","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.clindermatol.2007.08.006","article-title":"Comorbidities in psoriasis","volume":"25","author":"Christophers","year":"2007","journal-title":"Clin Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0575","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2005.12.006","article-title":"Inflammation: a pivotal link between autoimmune diseases and atherosclerosis","volume":"5","author":"Abou-Raya","year":"2006","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0580","doi-asserted-by":"crossref","first-page":"940","DOI":"10.7326\/0003-4819-122-12-199506150-00009","article-title":"Systemic lupus erythematosus: emerging concepts. Part 1: renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease","volume":"122","author":"Boumpas","year":"1995","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0585","first-page":"217","article-title":"Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis","volume":"145","author":"Kiss","year":"2004","journal-title":"Orv Hetil"},{"key":"10.1016\/j.autrev.2011.01.004_bb0590","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1196\/annals.1361.077","article-title":"Systemic lupus erythematosus, atherosclerosis, and autoantibodies","volume":"1051","author":"Zampieri","year":"2005","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0595","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12016-007-0009-8","article-title":"Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up","volume":"32","author":"Tarr","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0600","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/08916930903374527","article-title":"Atherosclerosis in systemic lupus erythematosus","volume":"43","author":"Sherer","year":"2010","journal-title":"Autoimmunity"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0605","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.autrev.2010.08.016","article-title":"Systemic lupus erythematosus: clinical presentations","volume":"10","author":"Smith","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0610","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00002281-200109000-00001","article-title":"Accelerated atherosclerosis in systemic lupus erythematosus: implications for patient management","volume":"13","author":"Salmon","year":"2001","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0615","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11926-009-0034-0","article-title":"Atherosclerosis risk factors in systemic lupus erythematosus","volume":"11","author":"Agarwal","year":"2009","journal-title":"Curr Rheumatol Rep"},{"issue":"11","key":"10.1016\/j.autrev.2011.01.004_bb0620","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/ard.62.11.1071","article-title":"Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus","volume":"62","author":"Doria","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0625","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.autrev.2008.10.002","article-title":"Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study)","volume":"8","author":"Colombo","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.01.004_bb0630","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1196\/annals.1422.009","article-title":"Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus","volume":"1108","author":"Kiss","year":"2007","journal-title":"Ann NY Acad Sci"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0635","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0002-9343(92)90578-Y","article-title":"Risk factors for coronary artery disease in patients with systemic lupus erythematosus","volume":"93","author":"Petri","year":"1992","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0640","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/03009740802541470","article-title":"Dyslipidaemia and lipoprotein pattern in systemic lupus erythematosus (SLE) and SLE-related cardiovascular disease","volume":"38","author":"Hua","year":"2009","journal-title":"Scand J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0645","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2007.01.003","article-title":"Cardiac manifestations in antiphospholipid syndrome","volume":"6","author":"Soltesz","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0650","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.autrev.2007.06.003","article-title":"OxLDL\/beta2GPI-anti-oxLDL\/beta2GPI complex and atherosclerosis in SLE patients","volume":"7","author":"Bassi","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2011.01.004_bb0655","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1196\/annals.1361.073","article-title":"OxLDL\/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement","volume":"1051","author":"Lopez","year":"2005","journal-title":"Ann NY Acad Sci"},{"issue":"Suppl 2","key":"10.1016\/j.autrev.2011.01.004_bb0660","first-page":"95","article-title":"Antiendothelial cell antibodies as a risk factor of atherosclerosis in systemic lupus erythematosus","volume":"52","author":"Fischer","year":"2006","journal-title":"Ann Acad Med Stetin"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0665","doi-asserted-by":"crossref","first-page":"R186","DOI":"10.1186\/ar2878","article-title":"Predictors of the first cardiovascular event in patients with systemic lupus erythematosus \u2014 a prospective cohort study","volume":"11","author":"Gustafsson","year":"2009","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0670","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.coi.2007.11.001","article-title":"Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association","volume":"19","author":"McMahon","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0675","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0165-2478(00)00287-X","article-title":"Levels of antibodies against C1q and 60kDa family of heat shock proteins in the sera of patients with various autoimmune diseases","volume":"75","author":"Horvath","year":"2001","journal-title":"Immunol Lett"},{"issue":"8","key":"10.1016\/j.autrev.2011.01.004_bb0680","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1191\/0961203305lu2157oa","article-title":"High sensitivity C-reactive protein in systemic lupus erythematosus: relation to disease activity, clinical presentation and implications for cardiovascular risk","volume":"14","author":"Barnes","year":"2005","journal-title":"Lupus"},{"issue":"1\u20132","key":"10.1016\/j.autrev.2011.01.004_bb0685","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1568-9972(01)00018-0","article-title":"High-density lipoprotein-associated apolipoprotein A\u2013I: the missing link between infection and chronic inflammation?","volume":"1","author":"Burger","year":"2002","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0690","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/0961203306lu2267oa","article-title":"Oxidized low-density lipoprotein and beta2-glycoprotein I in patients with systemic lupus erythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis","volume":"15","author":"Lopez","year":"2006","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.autrev.2011.01.004_bb0695","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1002\/art.10624","article-title":"Autoantibodies to lipoprotein lipase and dyslipidemia in systemic lupus erythematosus","volume":"46","author":"Reichlin","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0700","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1160\/TH06-10-0561","article-title":"Evaluation of antibodies to oxidized low-density lipoprotein and assessment of C-reactive protein in acute coronary syndrome and stable coronary artery disease","volume":"98","author":"Soltesz","year":"2007","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0705","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3109\/08916930903540440","article-title":"Oxidized LDL induces in vitro lymphocyte activation in antiphospholipid syndrome","volume":"43","author":"Laczik","year":"2010","journal-title":"Autoimmunity"},{"issue":"10","key":"10.1016\/j.autrev.2011.01.004_bb0710","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203306069972","article-title":"Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus","volume":"15","author":"de Leeuw","year":"2006","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.autrev.2011.01.004_bb0715","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0961203309103582","article-title":"Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis","volume":"18","author":"Chung","year":"2009","journal-title":"Lupus"},{"issue":"21","key":"10.1016\/j.autrev.2011.01.004_bb0720","first-page":"2593","article-title":"Expression of matrix metalloproteinase-1 mRNA in peripheral blood mononuclear cells of systemic lupus erythematosus patients and its relationship with atherosclerosis","volume":"122","author":"Zhang","year":"2009","journal-title":"Chin Med J (Engl)"},{"issue":"11","key":"10.1016\/j.autrev.2011.01.004_bb0725","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s10067-009-1228-6","article-title":"Subclinical atherosclerosis and endothelial dysfunction in young South-Asian patients with systemic lupus erythematosus","volume":"28","author":"Ghosh","year":"2009","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0730","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jaut.2006.09.008","article-title":"Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients","volume":"27","author":"Kiss","year":"2006","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0735","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.numecd.2008.09.009","article-title":"High prevalence of subclinical cardiovascular abnormalities in patients with systemic lupus erythematosus in spite of a very low clinical damage index","volume":"19","author":"Palmieri","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0740","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/03009740802007514","article-title":"Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus","volume":"37","author":"Svenungsson","year":"2008","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2011.01.004_bb0745","first-page":"273","article-title":"Endothelial activation, endothelial dysfunction and premature atherosclerosis in systemic autoimmune diseases","volume":"61","author":"Bijl","year":"2003","journal-title":"Neth J Med"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0750","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0961203308097571","article-title":"Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients","volume":"18","author":"Cacciapaglia","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.01.004_bb0755","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1196\/annals.1422.014","article-title":"Intima-media thickness: a marker of accelerated atherosclerosis in women with systemic lupus erythematosus","volume":"1108","author":"Colombo","year":"2007","journal-title":"Ann NY Acad Sci"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0760","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.24469","article-title":"Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort","volume":"60","author":"Schanberg","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0765","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/art.23196","article-title":"Progression of carotid intima-media thickness and plaque in women with systemic lupus erythematosus","volume":"58","author":"Thompson","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"16","key":"10.1016\/j.autrev.2011.01.004_bb0770","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1161\/hc4101.097518","article-title":"Risk factors for cardiovascular disease in systemic lupus erythematosus","volume":"104","author":"Svenungsson","year":"2001","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0775","first-page":"1300","article-title":"Coronary calcium in systemic lupus erythematosus is associated with traditional cardiovascular risk factors, but not with disease activity","volume":"35","author":"Kiani","year":"2008","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0780","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1191\/0961203303lu339oa","article-title":"Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients","volume":"12","author":"Soltesz","year":"2003","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0785","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12016-008-8099-5","article-title":"Antiphospholipid antibodies and atherosclerosis: insights from systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"37","author":"Ames","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0790","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.hoc.2007.10.007","article-title":"The clinical spectrum of antiphospholipid syndrome","volume":"22","author":"Baker","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0795","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1191\/0961203304lu1011oa","article-title":"Antiphospholipid antibodies in acute coronary syndrome","volume":"13","author":"Veres","year":"2004","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0800","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.autrev.2007.11.017","article-title":"Hughes Syndrome (the antiphospholipid syndrome): ten clinical lessons","volume":"7","author":"Hughes","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0805","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/0961203307080224","article-title":"Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome","volume":"16","author":"Der","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2011.01.004_bb0810","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1196\/annals.1422.055","article-title":"Peripheral vascular occlusions leading to gangrene and amputations in antiphospholipid antibody positive patients","volume":"1108","author":"Asherson","year":"2007","journal-title":"Ann NY Acad Sci"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0815","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/ard.2004.023952","article-title":"Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data","volume":"64","author":"Ames","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2011.01.004_bb0820","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/rheumatology\/ken349","article-title":"Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction","volume":"47","author":"Soltesz","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0825","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1078\/0171-2985-00215","article-title":"Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"207","author":"Alves","year":"2003","journal-title":"Immunobiology"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0830","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/0003319708315304","article-title":"Flow-mediated arterial dilation in primary antiphospholipid syndrome","volume":"60","author":"Bilora","year":"2009","journal-title":"Angiology"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0835","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1191\/0961203302lu165oa","article-title":"Anticardiolipin antibody titre and plasma homocysteine level independently predict intima media thickness of carotid arteries in subjects with idiopathic antiphospholipid antibodies","volume":"11","author":"Ames","year":"2002","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0840","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/rheumatology\/keh581","article-title":"Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome","volume":"44","author":"Jimenez","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0845","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/08916930903002487","article-title":"Mechanisms of vascular damage in systemic sclerosis","volume":"42","author":"Muller-Ladner","year":"2009","journal-title":"Autoimmunity"},{"issue":"2\u20133","key":"10.1016\/j.autrev.2011.01.004_bb0850","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-008-8105-y","article-title":"Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage?","volume":"36","author":"Szamosi","year":"2009","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0855","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ard.2006.066340","article-title":"Survival and causes of death in 366 Hungarian patients with systemic sclerosis","volume":"67","author":"Czirjak","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2011.01.004_bb0860","article-title":"Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality","author":"Nussinovitch","year":"2010","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0865","first-page":"527","article-title":"Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment","volume":"16","author":"Pignone","year":"1998","journal-title":"Clin Exp Rheumatol"},{"issue":"5\u20136","key":"10.1016\/j.autrev.2011.01.004_bb0870","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1159\/000163802","article-title":"In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease","volume":"61","author":"Koch","year":"1993","journal-title":"Pathobiology"},{"issue":"2 Pt 1","key":"10.1016\/j.autrev.2011.01.004_bb0875","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0190-9622(92)70165-C","article-title":"Expression of adhesion proteins involved in cell\u2013cell and cell\u2013matrix interactions in the skin of patients with progressive systemic sclerosis","volume":"27","author":"Gruschwitz","year":"1992","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0880","first-page":"629","article-title":"Anti-lipoprotein lipase antibody in systemic sclerosis: association with elevated serum triglyceride concentrations","volume":"32","author":"Kodera","year":"2005","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0885","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1186\/ar2408","article-title":"Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors","volume":"10","author":"Hettema","year":"2008","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2011.01.004_bb0890","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1196\/annals.1422.030","article-title":"Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis","volume":"1108","author":"Bartoli","year":"2007","journal-title":"Ann NY Acad Sci"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0895","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1007\/s10067-008-0958-1","article-title":"The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function","volume":"27","author":"Cypiene","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0900","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.10191","article-title":"Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production","volume":"46","author":"Andersen","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2011.01.004_bb0905","first-page":"1329","article-title":"Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis","volume":"35","author":"Timar","year":"2008","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2011.01.004_bb0910","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1097\/HJH.0b013e328244e1eb","article-title":"Arterial stiffness predicts severe progression in systemic sclerosis: the ERAMS study","volume":"25","author":"Constans","year":"2007","journal-title":"J Hypertens"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0915","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/rheumatology\/keh478","article-title":"Aortic stiffness in systemic sclerosis is increased independently of the extent of skin involvement","volume":"44","author":"Moyssakis","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2011.01.004_bb0920","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2999","article-title":"Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease","volume":"12","author":"Soltesz","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb0925","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-3083.2006.01770.x","article-title":"Clinical and immunoserological characteristics of mixed connective tissue disease associated with pulmonary arterial hypertension","volume":"64","author":"Vegh","year":"2006","journal-title":"Scand J Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0930","first-page":"409","article-title":"Anti-endothelial cell antibodies in mixed connective tissue disease: frequency and association with clinical symptoms","volume":"22","author":"Bodolay","year":"2004","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0935","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s10067-004-0911-x","article-title":"Mixed connective tissue disease associated with antineutrophil cytoplasmic antibodies against proteinase-3 and systemic atherosclerosis: a case report","volume":"23","author":"Kanazawa","year":"2004","journal-title":"Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2011.01.004_bb0940","first-page":"237","article-title":"Evaluation of paraoxonase activity in patients with mixed connective tissue disease","volume":"35","author":"Bodolay","year":"2008","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0945","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1002\/art.21475","article-title":"Precocious intima-media thickening in patients with primary Sjogren's syndrome","volume":"52","author":"Vaudo","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2011.01.004_bb0950","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.24836","article-title":"Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study","volume":"61","author":"Peters","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0955","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.berh.2005.05.001","article-title":"Cardiovascular disease in lupus patients: should all patients be treated with statins and aspirin?","volume":"19","author":"Bruce","year":"2005","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0960","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/rheumatology\/kei012","article-title":"Disease modification and cardiovascular risk reduction: two sides of the same coin?","volume":"44","author":"Hall","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0965","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/art.22094","article-title":"Antirheumatic drug use and the risk of acute myocardial infarction","volume":"55","author":"Suissa","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0970","doi-asserted-by":"crossref","first-page":"R151","DOI":"10.1186\/ar2045","article-title":"Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study","volume":"8","author":"van Halm","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"830","key":"10.1016\/j.autrev.2011.01.004_bb0975","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/pgmj.70.830.863","article-title":"Corticosteroids: do they damage the cardiovascular system?","volume":"70","author":"Maxwell","year":"1994","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.autrev.2011.01.004_bb0980","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/0002-9343(86)90639-X","article-title":"Is atherosclerosis a complication of long-term corticosteroid treatment?","volume":"80","author":"Nashel","year":"1986","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.autrev.2011.01.004_bb0985","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1002\/art.24040","article-title":"Atheroprotective effects of methotrexate on reverse cholesterol transport proteins and foam cell transformation in human THP-1 monocyte\/macrophages","volume":"58","author":"Reiss","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb0990","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","article-title":"Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis","volume":"41","author":"van Ede","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.autrev.2011.01.004_bb0995","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/03009749609069986","article-title":"Thrombosis and systemic lupus erythematosus: the Hopkins Lupus Cohort perspective","volume":"25","author":"Petri","year":"1996","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb1000","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.autrev.2009.03.001","article-title":"The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis","volume":"9","author":"van Leeuwen","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2011.01.004_bb1005","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/ard.2007.078287","article-title":"Anti-tumour necrosis factor agents and lipid profile: a class effect?","volume":"67","author":"Garces","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2011.01.004_bb1010","first-page":"83","article-title":"Anti-tumor necrosis factor-alpha blockade improves insulin resistance in patients with rheumatoid arthritis","volume":"24","author":"Gonzalez-Gay","year":"2006","journal-title":"Clin Exp Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211000097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997211000097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T08:34:06Z","timestamp":1740904446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997211000097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":202,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1568997211000097"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2011.01.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}